CPA1, carboxypeptidase A1, 1357

N. diseases: 61; N. variants: 2
Disease: Withdrawal Symptoms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0087169
Disease: Withdrawal Symptoms
Withdrawal Symptoms 		0.010 Biomarker phenotype BEFREE The aim of this study was to investigate the effects of the selective A<sub>1</sub> receptor agonist CPA (N<sup>6</sup> -cyclopentyladenosine) on withdrawal symptoms, and the concentration of dopamine and noradrenaline in the nucleus accumbens and locomotor activity behavior during naloxone-precipitated withdrawal in morphine-dependent rats. 31808190 2020